| Survivor | Non-survivor | p-value* |
---|---|---|---|
 | n = 82 | n = 22 | |
Demographics | |||
  Age (years), median (IQR) | 66 (56 to 76) | 70 (62 to 79) | 0.16 |
 Male, n (%) | 49 (60) | 14 (64) | 0.74 |
Underlying disease types | Â | Â | Â |
  Hematopoietic disorders, n (%) | 38 (46) | 12 (55) | 0.49 |
  Infectious diseases, n (%) | 36 (44) | 5 (23) | 0.07 |
  The others, n (%) | 8 (10) | 5 (23) | 0.10 |
Laboratory tests | |||
  Platelet (× 109/L), median (IQR) | 40 (22 to 60) | 18.5 (12 to 40) | 0.03 |
  D-dimer (µg/mL), median (IQR) | 16.3 (9.6 to 43.2) | 16.2 (11 to 111.2) | 0.27 |
  PT-INR, median (IQR) | 1.40 (1.13 to 1.55) | 1.47 (1.27 to 1.70) | 0.22 |
  Fibrinogen (g/L), median (IQR) | 2.9 (1.2 to 4.1) | 1.6 (1.2 to 3.0) | 0.12 |
  HMGB1a (ng/mL), median (IQR) | 6.8 (3.1 to 13.6) | 16.3 (8.5 to 66.9) |  < 0.001 |
  Histone H3a (ng/mL), median (IQR) | 2.1 (0.4 to 7.8) | 4.8 (2.4 to 31.6) | 0.002 |
  DIC score (point), median (IQR) | 5 (5 to 6) | 5 (5 to 6) | 0.40 |
  5 points, n (%) | 57 (70) | 13 (59) | 0.35 |
  6 points, n (%) | 18 (22) | 7 (32) | 0.34 |
  7 points, n (%) | 7 (9) | 2 (9) | 0.93 |
  8 points, n (%) | NA | NA | NA |
Anti-DIC agents | |||
  rhTM, n (%) | 50 (61) | 18 (82) | 0.07 |
  Antithrombin, n (%) | 18 (22) | 8 (36) | 0.17 |